State and Demographic Variation in Use of Depot Antipsychotics by Medicaid Beneficiaries with Schizophrenia

State and Demographic Variation in Use of Depot Antipsychotics by Medicaid Beneficiaries with Schizophrenia

Published: Jan 01, 2014
Publisher: Psychiatric Services, Vol. 65, No. 1
Download
Authors

Jonathan D. Brown

Allison Barrett

Emily Caffery

Henry T. Ireys

This study found the use of injectable antipsychotics varied substantially among state Medicaid programs. African Americans received a disproportionate share in many states.

How do you apply evidence?

Take our quick four-question survey to help us curate evidence and insights that serve you.

Take our survey